Advertisement

Topics

PubMed Journal Database | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics RSS

13:43 EST 22nd January 2019 | BioPortfolio

The US National Library of Medicine and National Institutes of Health manage PubMed.gov which comprises of more than 29 million records, papers, reports for biomedical literature, including MEDLINE, life science and medical journals, articles, reviews, reports and  books.

BioPortfolio aims to cross reference relevant information on published papers, clinical trials and news associated with selected topics - speciality.

For example view all recent relevant publications on Epigenetics and associated publications and clincial trials.

Showing PubMed Articles 1–25 of 333 from International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

Recurrence of endometrial carcinoma presenting as vulvar lesions.

Endometrial cancer is the most common gynecological malignancy in developed countries. Although this cancer generally carries a good prognosis, 10%-15% of patients will suffer recurrent disease and vulvar metastasis is extremely rare. A 60-year-old female (G3P3) was referred to the vulvo-vaginal clinic in Shaare Zedek Medical Center, Jerusalem, Israel, with a 3-month history of painful vulvar lesions that were initially treated by others for molluscum contagiosum. This article is protected by copyright. All...

Corrigendum to "The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions" Int J Gynecol Obstet 143(2018) 393-408..

Corrigendum to "Precancerous cervical lesions and HPV genotypes identified in previously unsatisfactory cervical smear tests after inexpensive glacial acetic acid processing" Int J Gynecol Obstet 2018. doi: 10.1002/ijgo.12699..

Timing of staples and dressing removal after cesarean delivery (the SCARR study).

To investigate optimal timing of dressing and staples removal after cesarean delivery (CD).

Using misoprostol to treat postpartum hemorrhage in home deliveries attended by traditional birth attendants.

To explore the clinical and programmatic feasibility of using 800 μg of sublingual misoprostol to prevent and treat postpartum hemorrhage (PPH) during home delivery.

Introducing a new collaborative prenatal clinic model.

To measure quality of care-planning for women in a new collaborative prenatal model of care.

Partnering with traditional Chiefs to expand access to cervical cancer prevention services in rural Zambia.

To evaluate how the influence of traditional Chiefs can be leveraged to promote access to cervical cancer prevention services in rural Zambia.

Doppler ultrasonographic assessment of fetal middle cerebral artery peak systolic velocity in gestational diabetes mellitus.

To compare Doppler ultrasonographic measurements of the fetal middle cerebral artery peak systolic velocity (MCA PSV) among women with or without gestational diabetes mellitus (GDM).

Use of the shock index to predict maternal outcomes in women referred for postpartum hemorrhage.

To evaluate the clinical significance of various vital signs in women referred for postpartum hemorrhage (PPH).

Three-dimensional Doppler ultrasonography for the assessment of fetal liver vascularization in fetuses with intrauterine growth restriction.

To demonstrate changes in hepatic volume and vascular indices in fetuses with intrauterine growth restriction (IUGR) compared with normal-growth fetuses, using a noninvasive method (three-dimensional power Doppler ultrasound).

The association of puerperal sepsis with HIV infection at two tertiary hospitals in Zimbabwe.

To evaluate the association between HIV infection and puerperal sepsis among women in Zimbabwe.

Systematic review of efficacy with extending contraceptive implant duration.

Extending contraceptive implant duration of use increases accessibility by maximizing the lifetime of devices.

Impact of reproductive evolutionary mismatch on women's health and the need for action and research.

Efforts by the health and scientific community have focused on providing women with the means to control and regulate their fertility. We paid less attention to the reality of women achieving their reproductive revolution while burdened with a reproductive system that evolved to fit the life of our ancestor hunter-gatherers, where women were destined to spend most of their reproductive years pregnant or breastfeeding. This state of evolutionary mismatch impacts on women's health as the reproductive system c...

Determinants of non-adherence to antiretroviral therapy among Option B+ cases in Ndop and Fundong health districts, Northwest Region, Cameroon.

2013 WHO guidelines recommend Option B+-antiretroviral therapy (ART) for life for all HIV-positive pregnant women-for prevention of mother-to-child transmission of HIV [1]. Between March 1 and April 30, 2016, we did a cross-sectional study with national ethics approval to establish the level of non-adherence and associated factors among pregnant women who had received Option B+ treatment for at least 6 months in Ndop and Fundong health districts in the Northwest Region of Cameroon. This article is protected...

Multicenter randomized controlled trial assessing the impact of a cervical traction maneuver (Amr's maneuver) on the incidence of postpartum hemorrhage.

To assess the impact of a cervical traction maneuver (Amr's maneuver) used in conjunction with active management of the third stage of labor (AMTSL) on the incidence of postpartum hemorrhage (PPH).

Determinants in the process of seeking help for urinary incontinence in the Chilean health system.

To analyze via the Andersen model what leads women with urinary incontinence (UI) to seek help and remain in the health care system.

Quantifying bias between reported last menstrual period and ultrasonography estimates of gestational age in Lusaka, Zambia.

To quantify differences in assessing preterm delivery when calculating gestational age from last menstrual period (LMP) versus ultrasonography biometry.

The moderating role of race/ethnicity on associations between insurance status and HPV vaccination among women in the USA.

To evaluate associations between insurance status and HPV vaccination.

Challenges in delivery and performance of a cervical cancer prevention program in the Kurdistan Region of the Iraq health system.

To investigate health-system challenges responsible for the poor performance of a cervical cancer prevention program in the Kurdistan Region of Iraq.

Improving the quality of maternity services in Nepal through accelerated implementation of essential interventions by healthcare professional associations.

To assess whether the implementation of a package of activities through the joint action of three international healthcare professional associations (HCPAs) increased the use of essential interventions (EIs) for delivery and neonatal care.

Risk of stillbirth among Zambian women with a prior cesarean delivery.

Cesarean delivery (CD) may be associated with stillbirth in future pregnancies. We investigated prior CD as a risk factor for stillbirth in Lusaka, Zambia.

Associations between postpartum depression and hypertensive disorders of pregnancy.

To identify possible relationships between postpartum depression and hypertensive disorders of pregnancy (HDP), as well as the associated risk factors for developing postpartum depression.

The addition of lymphadenectomy to secondary cytoreductive surgery in comparison with bulky node resection in patients with recurrent ovarian cancer.

To evaluate the role of full lymphadenectomy in patients with isolated nodal recurrence of ovarian cancer.

Spreading Latin American research at a global level.

Making HPV vaccination available to girls everywhere.

Cervical cancer is currently the fourth leading cause of cancer death among women worldwide, with most cases occurring in low- and middle-income countries. Safe, highly effective vaccines against human papillomavirus (HPV) have been on the market since 2006, yet only 6% of girls worldwide have received this life-saving cancer prevention intervention. International organizations, including PATH, Gavi, and the pharmaceutical companies Merck and GlaxoSmithKline, have provided support to eligible low- and middl...


Advertisement
Quick Search
Advertisement
Advertisement